Initial validation of the global assessment of severity of illness

This study assessed the validity of the Global Assessment of Severity of Illness (GASI), a single-item scale designed for quick and simple assessment of illness severity in children with various chronic physical conditions. Study objectives were to examine validity, reliability, and responsiveness of the GASI. Clinicians assessed the severity of asthma, food allergy, epilepsy, diabetes, and juvenile arthritis in 55 children, and parents reported on children ’s health-related quality of life. Area under the curve (AUC) computed by logistic regression and Kendall’s Tau-c (τc) assessed the strength of association between the GASI and other study measures. The  kappa coefficient (κ), weighted kappa (κw), and McNemar ’s test assessed stability in GASI ratings over time. The standardized response mean and Guyatt’s responsiveness index examined internal and external responsiveness of the GASI, respectively. The GASI correlated strongly with established severity scales (AUC = 0.83–0.96; τc = 0.57–0.78) and did not correlate with health-related quality of life (τc 
Source: Health Services and Outcomes Research Methodology - Category: Statistics Source Type: research

Related Links:

The approval is the second indication for the anti-interleukin 23 monoclonal antibody after approval for plaque psoriasis was granted in 2019.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news
FRIDAY, Jan. 21, 2022 -- Patients aged younger than 18 years with diagnosed COVID-19 have an increased risk for newly diagnosed diabetes>30 days after acute infection, according to research published in the Jan. 14 issue of the U.S. Centers for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Among US patients hospitalized for diabetic ketoacidosis (DKA), those with obesity hypoventilation syndrome had a higher risk of in-hospital mortality and other adverse outcomes.First Look
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Diabetes & Endocrinology News Source Type: news
BRUSSELS and ATLANTA, Jan. 21, 2022. UCB, a global biopharmaceutical company, today announced positive top-line results from the Phase 3 BE COMPLETE study, which evaluated the efficacy and safety of bimekizumab in the treatment of adults with active...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
FRIDAY, Jan. 21, 2022 -- Compared with sensor-augmented pump therapy, a hybrid closed-loop system improves glycemic control in young children with type 1 diabetes, according to a study published in the Jan. 20 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
FRIDAY, Jan. 21, 2022 -- For young children with peanut allergy, initiation of peanut oral immunotherapy is associated with an increase in desensitization and remission, according to a study published in the Jan. 22 issue of The Lancet. Stacie M....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
FRIDAY, Jan. 21, 2022 -- Some kids might be able to get over their peanut allergy if they start immunotherapy while they're still toddlers, a major new clinical trial reports. In the trial, a group of 1- to 3-year-olds with severe peanut allergies...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
(University of Waterloo) Researchers from the University of Waterloo surveyed children between the ages of six and 16, and all within a month of their diagnosis with asthma, food allergy, epilepsy, diabetes or juvenile arthritis.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
ConclusionThe PSS is valid and reliable in parents of children with chronic health conditions. ImplicationsHaving established robust psychometric properties of the PSS, research is needed to extend its utility and routine use in clinical and public health settings.
Source: Family Relations - Category: Psychiatry & Psychology Authors: Tags: Original Article Source Type: research
CONCLUSIONS: Findings extend the psychometric properties of the SPPC as a valid and reliable scale in children newly-diagnosed with chronic illness. PMID: 28747936 [PubMed]
Source: Journal of the Canadian Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Tags: J Can Acad Child Adolesc Psychiatry Source Type: research
More News: Allergy | Allergy & Immunology | Arthritis | Asthma | Children | Diabetes | Endocrinology | Epilepsy | Food Allergy | Pediatrics | Rheumatology | Statistics | Study